<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102484">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01869660</url>
  </required_header>
  <id_info>
    <org_study_id>SDMS-S</org_study_id>
    <nct_id>NCT01869660</nct_id>
  </id_info>
  <brief_title>Shared Decision Making for Patients With First-admission Schizophrenia</brief_title>
  <official_title>Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yokohama City University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Yokohama City University</source>
  <oversight_info>
    <authority>Japan: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine whether shared decision making (SDM) intervention improves patient satisfaction
      in patients with first-admission schizophrenia compared with usual care.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2013</start_date>
  <completion_date type="Anticipated">October 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Patient satisfaction as measured by the Japanese version of the Client Satisfaction Questionnaire (CSQ-8)</measure>
    <time_frame>Within 7days before the date of discharge</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Attitude toward medication as measured by the Japanese version of the Drug Attitude Inventory (DAI-10)</measure>
    <time_frame>Within 7days before the date of discharge</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Treatment continuation as measured by the rate of outpatient attendance during the 30 days</measure>
    <time_frame>6 months after discharge</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">52</enrollment>
  <condition>Schizophrenia</condition>
  <arm_group>
    <arm_group_label>Shared Decision Making</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The present SDM intervention is based on principles derived from previous randomized controlled trials of SDMs. SDM meetings comprise at least 4 weekly 20 minutes sessions. Meetings have at least three professionals: a case manager (psychiatrists or nurses), a primary doctor, and a nurse/social worker. The focus of the meeting is to empower patients to discuss their attitudes and preferences toward treatments.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Usual Care</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with no special program about decision making.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Shared Decision Making</intervention_name>
    <description>The focus of the SDM is to empower patients to discuss their attitudes and preferences toward treatments.</description>
    <arm_group_label>Shared Decision Making</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted to an acute care psychiatric ward.

          -  Diagnosed with schizophrenia (ICD-10 codes: F20-F29)

          -  Aged 16 to 65 years old at admission

          -  No prior experience of psychiatric admission (first-admission)

        Exclusion Criteria:

          -  Diagnosed with moderate to severe mental retardation

          -  Diagnosed with organic mental disorders (ICD10 codes: F00-F09)

          -  Having poor Japanese language skill

          -  Severe conceptual disorganization as measured by brief psychiatric rating scale of 5
             or more.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yoshio Hirayasu, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Psychiatry, Yokohama City University School of Medical</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mio Ishii, MD</last_name>
    <email>t126012f@yokohama-cu.ac.jp</email>
  </overall_contact>
  <location>
    <facility>
      <name>Numazu Chuou Hospital</name>
      <address>
        <city>Numazu</city>
        <state>Shizuoka</state>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mio Ishii, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Japan</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 4, 2014</lastchanged_date>
  <firstreceived_date>May 27, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>First hospitalization</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Schizophrenia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
